Cora Health review

Cora Health offers compounded semaglutide and tirzepatide with online clinician review, home delivery and ongoing messaging. Its strongest public disclosures are the flexible monthly prices, named clinical group and named pharmacy partners. The much lower headline price belongs to an annual prepayment, so it is worth separating the affordable-looking monthly equivalent from the amount actually charged.

For women, Cora is a general weight-management service. Its current pages explain switching and medication safety in some detail, but do not establish a dedicated menopause or PCOS clinic. This review assesses the published service and terms, including the commitments behind its advertised prices.

How much does Cora Health cost?

The standard month-to-month prices are $175 for compounded semaglutide and $225 for compounded tirzepatide. Cora says medication, consultations and shipping are included, with no separate membership fee. It also says the standard plan price stays the same when the clinician adjusts the dose.

The semaglutide headline of $99 per month is the annual plan: $1,188 billed every 12 months, renewing until canceled. Tirzepatide's annual equivalent starts at $135 per month. These are different purchase commitments from paying $175 or $225 each month. Confirm the actual amount charged and the renewal date before selecting a longer plan.

The homepage also displays a $15 first-month code. A small introductory discount is separate from the continuing price and should not decide whether the program is affordable over a year. A prepaid plan can be cheaper per month while being harder to leave if you dislike the medication or your clinician changes treatment.

Cora has a separate microdose catalog and other compounded products. Their existence does not change the standard plan's pricing or prove that additional prescriptions are needed. Compare each proposed treatment individually, including its indication, quantity, schedule and cancellation terms.

Who provides the medical care?

Cora identifies Wasef Health, PC as the independent medical group. The current site lists Dr. David Wasef, Dr. Michael Wasef and other network physicians, with their specialties and biographies. Cora says it does not employ, direct or supervise those doctors and does not itself prescribe medication.

That separation is useful when deciding whom to contact. Questions about side effects or whether to change a dose belong with the prescribing clinician. A billing representative can help with account problems, but should not be the person deciding whether a prescription is medically suitable.

The company describes an online questionnaire and provider review, typically within a day. Its published timing is an estimate, not guaranteed approval. A clinician may need additional history before deciding. The site also advertises 24/7 messaging access; that means messages can be sent at any time, rather than proving every medical message receives an immediate answer.

Diet and workout plans are included in the broader standard-plan description. The pages reviewed do not establish a fixed schedule of laboratory monitoring or recurring specialist appointments. Ask what follow-up occurs after the first prescription and who orders, reviews and pays for any tests needed in your case.

Which pharmacies and medications are involved?

Cora's FAQ identifies Hallandale Pharmacy and VialsRx. It specifically describes Hallandale as PCAB-accredited and VialsRx as a U.S.-licensed 503A pharmacy. Those are different descriptions; it would be inaccurate to transfer Hallandale's accreditation statement to every possible dispenser.

Ask which pharmacy is assigned to your prescription, what the preparation contains and how much is dispensed. A named network is more useful when it leads to an actual medication label, pharmacy telephone number and clear written instructions. Cora's disclaimer correctly distinguishes compounded preparations from approved Ozempic, Wegovy, Mounjaro and Zepbound.

The standard products reviewed are compounded injections, rather than a promise of brand-name access at the same price. Our compounded versus brand-name GLP-1 guide explains why active-ingredient names alone do not establish equivalent products or outcomes.

What should women and switching patients ask?

Cora says patients transferring from another GLP-1 service should have their prior prescription or vial or pen label, last dose and date ready. Continuing the old dose is not guaranteed. That is a sensible distinction: a subscription transfer should not be mistaken for a clinician agreeing that the previous schedule remains appropriate.

For a woman with PCOS, ask whether Cora's clinician is treating weight alone and who continues to manage menstrual symptoms, fertility goals and other prescriptions. The public pages do not describe a comprehensive PCOS pathway. Our GLP-1 and PCOS guide can help frame that conversation.

Similarly, a woman taking HRT should disclose it during assessment and ask how information can be shared with her menopause clinician. General weight care and dedicated menopause management are different services. Our GLP-1 and HRT guide explains the coordination questions without assuming the two treatments belong in every plan.

Where is Cora available, and can you leave?

Cora advertises its standard plans in all 50 states. Product-specific and clinical eligibility still matter, and the microdose catalog should not automatically inherit every standard-plan statement. The company estimates most shipments arrive within three days after leaving the pharmacy; approval and preparation occur before that delivery period.

The refund policy distinguishes stopping a renewal from reversing an order already prepared. Review the preparation cutoff, especially with a multi-month purchase, and keep cancellation confirmation. A long plan is not equivalent to twelve refundable monthly purchases simply because the price is displayed per month.

Cora makes the most sense for someone comfortable with compounded general weight care who values named partners and transparent flexible pricing. Its annual offer deserves consideration only after the full upfront charge, pharmacy assignment and refund conditions are clear.